1 Day
Source:
بوابة الشروق
_1777352142843_145525226.png){kind=small}
Oxford Immunology Expert on Cancer Drug Prices
Professor Ahmed Salaman, an immunology and vaccine development expert at Oxford University, stated that research is increasingly moving toward relying on immunotherapy to treat tumors and cancers, with a focus on using vaccines against cancerous diseases alongside immune-based therapies. He explained that antibody technologies have experienced a significant decrease in their costs, dropping from around $20,000 per dose to between $500 and $600, which enhances the efficiency of targeted treatments that involve examining cancer cells and designing personalized therapies for each patient. This development occurs amid the continued use of traditional chemotherapies and radiation treatments in combination with immunotherapy.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)